2 comentários:
De gato a 27 de Outubro de 2021
Naturalmente que não se deu relêvo ao que segue:

Entre Março e Abril de 2020 (!!!) a firma Roche lançava, nos EUA, um "kit" que distinguia Gripes A, B e Coronas numa só amostra. Não convinha que se lhe desse importância.
Lá, como cá, há muitos de frosques a comer das farmacêuticas.

David E. Martin testifies at the German Corona Inquiry Committee, July 9th, 2021:

«... and this patent sought by the CDC was allegedly justified by their public relations team as being sought so that everyone would be free to be able to research coronavirus the only problem with that statement is it’s a lie and the reason why it’s a lie is because the patent office not once but twice rejected the patent on the gene sequence as unpatentable because the gene sequence was already in the public domain in other words prior to CDC’s filing for a patent the patent office found 99.9 percent identity with the already existing coronavirus recorded in the public domain...»

«... Now what’s important is on the 28th of April and listen to the date very carefully because this date is problematic.
Three days after CDC filed the patent on the SARS coronavirus in 2003, three days later sequoia pharmaceuticals a company that was set up in Maryland sequoia pharmaceuticals on the 28th of April 2003 filed a patent on antiviral agents of treatment and control of infections by coronavirus CDC filed three days earlier and then the treatment was available three days later
Now just hold that thought for a second who is sequoia pharmaceuticals? ...»

De Bic Laranja a 27 de Outubro de 2021
Naturalmente que se não deu relêvo isso da Roche nem a D. Martin ou aos outros ouvidos pelo Comité alemão do Corona. Mas há-se de vir a dar. Temo é que seja já fora de tempo…